SCHEMBL6164530

SCHEMBL6164530

COc1cccc(OC)c1-c1nn(-c2ccc(Cl)nn2)c2c1C(=O)CCC2(C)C

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
RAB9A P51151 1/20 0.35
APP P05067 1/20 0.33
MAPT P10636 1/20 0.33
POLL Q9UGP5 1/20 0.32
MAOB P27338 1/20 0.32
HTR2C P28335 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166539 0.85 SRC (0.39) ALDH1A1CCNA2CDK2SMN1; SMN2RAB9A
SCHEMBL6167058 0.84 KDM4E (0.41) ALDH1A1LMNACCNA2CDK2SMN1; SMN2
SCHEMBL6163996 0.84 ALDH1A1 (0.39) ALDH1A1LMNACCNA2CDK2SMN1; SMN2
SCHEMBL6166406 0.81 CCNA2 (0.41) ALDH1A1CCNA2CDK2SMN1; SMN2RAB9A
SCHEMBL6164575 0.80 CCNA2 (0.38) ALDH1A1CCNA2CDK2SMN1; SMN2RAB9A
SCHEMBL6162683 0.80 CCNA2 (0.38) ALDH1A1CCNA2CDK2SMN1; SMN2RAB9A
SCHEMBL6166604 0.79 CCNA2 (0.39) CCNA2CDK2SMN1; SMN2RAB9AAPP
SCHEMBL6162854 0.77 CCNA2 (0.36) ALDH1A1CCNA2CDK2SMN1; SMN2RAB9A
SCHEMBL6185430 0.76 CCNA2 (0.43) ALDH1A1LMNACCNA2CDK2SMN1; SMN2
SCHEMBL6167233 0.75 CDK2 (0.39) ALDH1A1LMNACCNA2CDK2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed